C. John Blankley

Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus

Bruce D. Roth, C. John Blankley, Alexander Chucholowski et al. · Journal of Medicinal Chemistry · 1991 · 183 citations · Full text

Life Sciences, Biochemistry, Pharmacology +13

Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype

C. John Blankley, John C. Hodges, S. KLUTCHKO et al. · Journal of Medicinal Chemistry · 1991 · 162 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Antihypertensive activity of 6-arylpyrido[2,3-d]pyrimidin-7-amine derivatives

Lawrence R. Bennett, C. John Blankley, Robert W. Fleming et al. · Journal of Medicinal Chemistry · 1981 · 110 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types

S. KLUTCHKO, C. John Blankley, Robert W. Fleming et al. · Journal of Medicinal Chemistry · 1986 · 83 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Preparation and decomposition of unsaturated esters of diazoacetic acid

Herbert O. House, C. John Blankley · The Journal of Organic Chemistry · 1968 · 74 citations

Natural Sciences, Chemistry, Analytical Chemistry +4